Skip to main content

Table 1 Geographical locations of SARS-CoV-2 specimens and cases

From: A database for retrieving information on SARS-CoV-2 S protein mutations based on correlation network analysis

Nation

Specimens (S)

Cases (C)

Ratio (S/C)

United States

1,816,065

73,958,288

2.4%

United Kingdom

1,307,360

17,405,439

7.5%

Germany

276,777

9,978,146

2.7%

Switzerland

99,615

2,268,533

4.3%

Australia

13,312

2,182,390

0.6%

Slovakia

10,409

1,022,784

1.0%

Iceland

5,365

67,594

7.9%

Bahrain

4,946

374,575

1.3%

Kenya

4,013

321,381

1.2%

Mexico

2,950

5,198,891

 < 0.1%

Denmark

2,599

1,742,569

0.1%

India

2,552

41,469,499

 < 0.1%

New Zealand

2,427

16,246

14.9%

Japan

2,195

2,730,828

 < 0.1%

Hong Kong

1,853

–

–

France

1,712

18,634,317

 < 0.1%

Estonia

1,681

344,060

0.4%

Netherlands

1,562

4,420,834

 < 0.1%

Puerto Rico

1350

457,501

0.2%

Bangladesh

1,233

1,811,987

 < 0.1%

Poland

1,219

4,925,158

 < 0.1%

Spain

1,184

10,100,109

 < 0.1%

Brazil

1,121

25,348,797

 < 0.1%

Thailand

1,106

2,447,964

 < 0.1%

Saudi Arabia

1,090

687,264

0.1%

Egypt

1,072

425,911

0.2%

Italy

1,063

10,983,116

 < 0.1%

  1. Nations providing one thousand or more specimens are listed. The numbers of specimens and cases were obtained from different data sources (NCBI Virus SARS-CoV-2 Data Hub and WHO Coronavirus Dashboard databases, respectively). Therefore, these specimens are not necessarily included in the number of cases